β 1 -and β 2 -Adrenergic receptors (β 1 -AR and β 2 -AR) are co-expressed in numerous tissues, for example, heart and bladder. They play a very important role in the responses of a variety of organs to sympathetic nerve stimulation. Recent studies suggest that many G protein-coupled receptors, such as β 1 -AR, β 2 -AR, μ opioid receptor and δ opioid receptor, can form homo-and heterooligomers. Previous studies demonstrated that the β 1 -AR and β 2 -AR formed dimers in living HEK 293 cells. The aim of the present study is to investigate whether such heterooligomerization affect the agonist-induced receptor internalization in the CHO-K1 cells stably co-expressing β 1 -AR and β 2 -AR. Using co-immunoprecipitation, we confirmed that β 1 -AR and β 2 -AR formed heterooligomers in the CHO-K1 cells. In cells co-expressing β 1 -AR and β 2 -AR, 30% of β 1 -AR was internalized by isoproterenol, whereas only 20% of β 1 -AR was internalized in cells expressing the β 1 -AR alone. Heterooligomerization did not affect the ratio of internalized β 2 -AR. Salmeterol, a specific β 2 -AR agonist, broke β 1 -AR/β 2 -AR heterooligomers, and induced β 2 -AR-specific internalization in cells co-expressing β 1 -AR and β 2 -AR. The present study demonstrated that heterooligomerization between β 1 -AR and β 2 -AR accelerates the isoproterenol-promoted internalization of the β 1 -AR, and that salmeterol induces β 2 -AR-specific internalization in Chinese hamster ovary (CHO) cells stably co-expressing β 1 -AR and β 2 -AR.
GTP-binding protein (G protein)-coupled receptors (GPCR) control many important functions of eukaryotic organisms, such as regulation of circulatory system, neurotransmission, immune response, cell growth, and metabolism. Recently, several reports suggest that GPCR exist and work as homoand/or heterooligomers. 1, 2) Forming hetero-oligomers among GPCR has been shown to modulate ligand binding, the coupling with G protein, internalization, and desensitization. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] β 1 -and β 2 -Adrenergic receptors (β 1 -AR and β 2 -AR) are widely distributed and co-expressed in various tissues and cell types. [19] [20] [21] [22] [23] Both β 1 -AR and β 2 -AR are known to couple to G s , there are some important differences in their functional properties, such as receptor internalization. Rapid internalization of β 2 -AR occurred following stimulation with β-agonist, whereas most of β 1 -AR stayed at the cell surface following agonist stimulation for longer period. 24, 25) Shiina et al. proposed that weak interaction of β 1 -AR with β-arrestins explained the resistance to agonist-induced internalization. 26) β 1 -AR and β 2 -AR were shown to form homodimers when each of the receptors individually expressed in mammalian cells. [27] [28] [29] Lavoie et al. demonstrated that the two receptors formed heterodimers, and that the heterodimerization inhibits the agonist-promoted internalization of the β 2 -AR in HEK 293 cells transiently expressing the two receptors. 16) However, down regulation of β 1 -AR is widely observed in cardiomyocytes treated with β-agonist. 30) It is commonly believed that receptor down regulation occurs following receptor internalization. It has been reported co-internalization between β 2 -AR and α 1D -adrenergic receptor (α 1D -AR) after stimulation by salbutamol, a β 2 -AR specific agonist, whereas α 1D -AR is hardly internalized by agonist stimulation when expressing alone. 31) Taken together, we hypothesized that β 1 -AR may co-internalize with β 2 -AR after agonist stimulation in different experimental condition. In the present study, we did not select transient expression system, but stable expression system, to make the cells co-expressing the two receptors.
In the present study, formation of heterooligomerization between the β 1 -AR and β 2 -AR was assessed by co-immunoprecipitation in mammalian cells not transiently but stably co-expressing the two receptors. We tested whether the heterooligomerization affect receptor internalization induced by isoproterenol, a non-selective β-agonist, and salmeterol, a specific β 2 -agonist in the mammalian cells stably co-expressing β 1 -AR and β 2 -AR. We found that heterooligomerization between β 1 -AR and β 2 -AR accelerates the isoproterenolpromoted internalization of the β 1 -AR, and that salmeterol induces β 2 -AR-specific internalization in Chinese hamster ovary (CHO) cells stably co-expressing β 1 -AR and β 2 -AR.
MATERIALS AND METHODS

Eukaryotic Expression Vectors. β 1 -AR with Blue Fluorescent Protein (BFP)
The human β 1 -AR coding sequence without its stop codon was amplified from the pCMV5-β 1 -AR plasmid using sense and antisense primers harboring unique BamHI and SmaI sites. The fragment was then subcloned in frame into the BamHI/SmaI site of pBluescript-sk(−) (Stratagene, Santa Clara, CA, U.S.A.) to give the plasmid pBluescript-sk(−)-β 1 -AR. The pBluescript-sk(−)-β 1 -AR was cut by SmaI and HindIII and the fragment was subcloned in frame to NheI blunt-ended by T4 DNA polymerase/HindIII site of pQBI 50-fN1 (Qbiogene, Solon, OH, U.S.A.) to give the plasmid pQBI 50-fN1-β 1 -AR. Finelly, pQBI 50-fN1-β 1 -AR was cut by MluI and blunt-ended by T4 pDNA polymerase, and then cut by HindIII. The fragment containing β 1 -AR with BFP at the 5′-terminus of the β 1 -AR was subcloned into the EcoRV/HindIII site of the pcDNA 3.1 Hygro (+) to finally yield pcDNA 3.1 Hygro (+)-β 1 -AR-BFP. β 2 -AR with Enhanced Yellow Fluorescent Protein (EYFP) The human β 2 -AR coding sequence without its stop codon was amplified from the pBC-β 2 -AR plasmid using sense and antisense primers harboring unique BamHI and EcoRV sites. The fragment was then subcloned in frame into the BamHI/EcoRV site of pBluescript-sk(−) to give the plasmid pBluescript-sk(−)-β 2 -AR. Finally, the pBluescript-sk(−)-β 2 -AR was cut by BamHI and EcoRI and the fragment was subcloned in frame to EcoRI/BamHI site of pEYFP-N1 to give the plasmid pEYFP-N1-β 2 -AR.
CHO-K1 Cells Stably Expressed β-AR The pcDNA 3.1 Hygro (+)-β 1 -AR-BFP, the pEYFP-N1-β 2 -AR, and the both vectors were transfected into CHO-K1 cells using Lipo-fectAMINE™ reagent (Invitrogen, Carlsbad, CA, U.S.A.). The stable transformants were selected in Ham's F-12 supplemented with 10% fetal bovine serum and 1 g/L G418 sulfate and/or 200 µg/mL hygromycin in atmosphere of 95% air and 5% CO 2 at 37°C. CHO-K1 cells expressed the β 1 -AR with blue fluorescent protein at the N-terminus, β 2 -AR with EYFP tag at the N-terminus, and the two receptors were grown as monolayer in Ham's F-12 supplemented with 10% fetal bovine serum and 300 mg/L G418 sulfate and/or 200 µg/mL hygromycin in atmosphere of 95% air and 5% CO 2 at 37°C. Expression of β 1 -AR and β 2 -AR was determined by radioligand receptor binding assay using (−)-[ 3 H]-CGP12177 as described below.
Radioligand Receptor Binding Assay Using Intact Cells To detect only β-AR at the cell surface, radioligand receptor binding studies were carried out using intact cells cultured with 6 or 12-well plates. The cells were cultured until 90% confluent. When receptor internalization was assessed, the cells were washed three times with Krebs-bicarbonate buffer (37°C), comprised of 119 mm NaCl, 4.8 mm KCl, 1.2 mm MgSO 4 , 1.2 mm KH 2 PO 4 , 2.5 mm CaCl 2 , 25 mm NaHCO 3 , 10 mm glucose, and 1 mm l-ascorbic acid, gassed with 95% O 2 and 5% CO 2 . And then, 1 mL of Krebs-bicarbonate buffer was added. To induce receptor internalization, 10 µm isoproterenol (Sigma, St. Louis, MO, U.S.A.), or 5 or 50 nm salmeterol (Glaxo Smith Kline, London, U.K.) was added to the buffer and the cells were incubated in atmosphere of 95% air and 5% CO 2 at 37°C for 30 min. The cells were washed three times with 1 mL of ice-cold Krebs buffer (pH 7.4), comprised of 119 mm NaCl, 4.8 mm KCl, 1.2 mm MgSO 4 , 1.2 mm KH 2 PO 4 , 2.5 mm CaCl 2 , 10 mm glucose, 10 mm N-(2-hydroxyethyl)piperazine-N′-2-ethanesulfonic acid (HEPES) and 1 mm lascorbic acid, and then 1 mL of ice-cold Krebs buffer was added. For saturation isotherms, membranes were incubated with various concentrations of (−)-[ 3 H]-CGP12177, a hydrophilic ligand for β-AR, (0-3 nm) in the absence or presence of 10 µm (± )-propranolol. Competition binding studies were carried out using 6 nm (−)-[ 3 H]-CGP12177 and various concentrations (0-100 µm) of CGP20712A, a β 1 -AR specific antagonist, and ICI118551, a β 2 -AR specific antagonist. The reaction was stopped by washing the cells three times with 1 mL of ice-cold Krebs buffer. The cells were collected with 500 µL of 0.05% Trypsin, and 4 mL of scintillation cocktail (Clearsol I, Nacalai Tesque, Kyoto, Japan) was added. The radioactivity remaining on the cell was counted by a liquid scintillation counter.
Membrane Preparation The cells with or without agonist stimulation for 30 min at 37°C were washed 3 times with ice-cold phosphate buffered saline and scraped in 1 mL of lysis buffer, comprising of 10 mm Tris-HCl (pH 7.4), 5 mm ethylenediaminetetraacetic acid (EDTA), 5 mm ethylene glycol bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 2.5 µg/mL pepstatin A, 0.1 mm phenylmethylsulfonylfluoride and 1 µm leupeptin. The cells were homogenized with a homogenizer (model MICCRA D-8, ART moderne Labortechnik, Müllheim, Germany) and centrifuged at 45000×g for 30 min at 4°C. The supernatant was discarded and the pellet was resuspended in 10 mm HEPES-NaOH (pH 7.4). The resuspended membrane was frozen with liquid nitrogen and stocked at −80°C until use.
Cell Lysate Preparation The cells with or without agonist stimulation for 30 min at 37°C were washed 3 times with ice-cold phosphate buffered saline and scraped in 1 mL of radioimmune precipitation (RIPA) buffer containing 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 0.1 mm phenylmethylsulfonyl fluoride, 1 µm leupeptin and 2.5 µg/mL pepstatin A in phosphate buffered saline. The cells were homogenized with a homogenizer (model MICCRA D-8, ART moderne Labortechnik) and centrifuged at 45000×g for 30 min at 4°C. The supernatant was used for immunoprecipitation.
Immunoprecipitation The resuspended membrane were solubilized in RIPA buffer for 30 min at 4°C and centrifuged at 12000×g for 30 min at 4°C to remove cellular debris. For pre-cleaning, the solubilized membrane or the cell lysate was incubated with 30 µL of protein G-sephasore beads (GE bioscience) for 30 min at 4°C. After protein G-sephasore beads were removed, the solution was incubated with 3 µg of anti-β 1 -AR antibody (Research Diagnostics, Flanders, NJ, U.S.A.) overnight at 4°C. Thereafter, 30 µL of protein G-sephasore beads were added, and the solution was incubated for 60 min at 4°C. Protein G-Sepharose-antibody-antigen complexes were then collected by centrifugation at 12000×g. The immunoprecipitates were washed four times with cold radioimmune precipitation buffer and resuspended in 30 µL of 2× sample buffer containing 65 mm Tris-HCl, pH 6.5, 3% SDS, 10% glycerin and 0.02% bromo phenol blue and heated at 100°C for 5 min. When breakdown of disulfide bond is needed, 50 mm dithiothreitol was added to the sample buffer.
Western Blot Protein samples were resolved by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE), transferred to polyvinylidene fluoride (Bio-rad, Hercules, CA, U.S.A.), and subjected to immunoblotting using rabbit polyclonal anti-β 1 -AR antibody (Research Diagnostics, Flanders, NJ, U.S.A.) or anti-β 2 -AR antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). The Renaissance chemiluminescence kit (PerkinElmer Life Sciences, Boston, MA, U.S.A.) was used for development.
Data Analysis and Statistics Data from radioligand saturation assays and competition curves were fitted by nonlinear least-squares analysis using a computer program, GraphPad Prism (GraphPad software, La Jolla, CA, U.S.A.). The maximum binding capacity (B max ) of (−)-[ 3 H]-CGP12177 was calculated from Scatchard analysis. All results were expressed as means± S.E.M. One-way analysis of variance followed by Tukey-Kramer test was used for multiple comparisons. Differences were considered to be statistically significant when the p value was less than 0.05.
RESULTS
Expression Level of β-AR Specific binding of (−)-[ 3 H]-CGP12177 to each of the cells expressing β 1 -AR, β 2 -AR, or both β 1 -AR and β 2 -AR was monophasic and saturable. The B max values of the cells expressing β 1 -AR, β 2 -AR, and both β 1 -AR and β 2 -AR were 489± 34 fmol/mg protein, 584± 23 fmol/ mg protein, and 389± 16 fmol/mg protein, respectively. From the results of the competition of (−)-[ 3 H]-CGP12177 binding with CGP20712A, a β 1 -AR specific antagonist, and ICI118551, a β 2 -AR specific antagonist, 1 µm CGP20712A and 0.1 µm ICI118551 specifically blocked their target receptor in the CHO-K1 cells expressing both β 1 -AR and β 2 -AR. From the results of the saturation binding of (−)-[ 3 H]-CGP12177 with 1 µm CGP20712A and 0.1 µm ICI118551, the B max values were 338± 7 fmol/mg protein and 89± 4 fmol/mg protein, respectively, indicated that the expression ratio (β 1 -AR : β 2 -AR) is 1 : 4.
Receptor Internalization To quantify the proportion of the β 1 -AR internalized in the presence and absence of the β 2 -AR, radioligand receptor binding studies were carried out using (−)-[ 3 H]-CGP12177, a hydrophilic ligand for β-AR in the intact CHO-K1 cells stably expressing both β 1 -AR and β 2 -AR. The amount of β 1 -AR internalized from the cell surface after 30 min of stimulation with 10 µm isoproterenol was approximately 30% as measured with 0.1 µm ICI118551 to isolate the specific binding of β 1 -AR, whereas approximately 20% of β 1 -AR internalized from the surface after 30 min of stimulation with 10 µm isoproterenol in the CHO-K1 cells expressing only β 1 -AR (Fig. 1A) . In contrast, stimulation with 50 nm salmeterol, a specific agonist for β 2 -AR, for 30 min did not induce the internalization of β 1 -AR in the cells expressing both β 1 -AR and β 2 -AR. Co-expression with β 1 -AR did not affect the amount of the internalized β 2 -AR after 30 min of stimulation with isoproterenol and salmeterol (Fig. 1B) . We observed almost the same results in another CHO-K1 cell clone expressing both β 1 -AR and β 2 -AR (expression ratio (β 1 -AR : β 2 -AR) is 4 : 1, total B max is 4.2± 0.5 pmol/mg protein). In the previous report, 100 nm salmeterol was reported not to displace the binding of [ 3 H]-CGP12177, and to induce accumulation the very small amount of cGMP in β 1 -CHO, 32) suggesting 50 nm salmeterol only has vary small affinity to β 1 -AR in β 1 -CHO. Therefore, we did not investigate the effect of salmeterol on internalization of β 1 -AR in β 1 -CHO.
Detection of Heterooligomer of β 1 -AR and β 2 -AR by Co-immunoprecipitation
To determine whether the β 1 -AR and β 2 -AR could form a heterooligomer, a co-immunoprecipitation experiment between β 1 -AR and β 2 -AR was investigated. Immunoprecipitation of β 1 -AR using a rabbit polyclonal anti-β 1 -AR antibody was done using the membrane fraction and the lysate of the cells expressing both β 1 -AR and β 2 -AR, and then β 2 -AR in the immunoprecipitant was probed using a rabbit anti-β 2 -AR antibody. One major band corresponding to oligomeric form of the β 2 -AR was detected at about 200 kDa ( Fig. 2A) . Although we could not conclude that the band represented dimers or possibly higher order oligomers such as trimmers or tetramer because of the low resolution in this region of the SDS-polyacrylamide gels, this result indicated that the β 1 -AR and β 2 -AR could form heterooligomer, and that the heterooligomer was SDS-resistant complex. When the disulfide bonds in the immunoprecipitant was reduced by dithiothreitol, the 200 kDa band disappeared, and three specific bands were detected at about 80 kDa, 100 kDa and 150 kDa (Fig. 2B) .
Effect of Agonist Stimulation on Oligomelization of β 1 -AR
To determine the effect of agonist stimulation on oligomelization of β 1 -AR, immunoprecipitation experiment using anti-β 1 -AR antibody was investigated. Immunoprecipitation of β 1 -AR using a rabbit polyclonal anti-β 1 -AR antibody was done using the lysate of the cells expressing both β 1 -AR and β 2 -AR with or without agonist stimulation, and then β 1 -AR in the immunoprecipitant was probed using a rabbit anti-β 1 -AR antibody. The band corresponding to oligomeric form of the β 1 -AR was detected at about 200 kDa, as the coimmunopricipitation experiment. In the lysate of the salmeterol-treated cells, not in isoproterenol-treated cells, the band at 50 kDa, corresponding to monometric form of the β 1 -AR, appeared (Fig. 2C ).
DISCUSSION
It is widely known that both the β 1 -AR and the β 2 -AR are expressed in cardiomyocytes. 20) In the present study, we confirmed that β 1 -AR and β 2 -AR formed heterooligomers, and demonstrated that heterooligomerization between β 1 -AR and β 2 -AR accelerates the isoproterenol-promoted internalization of the β 1 -AR, and that salmeterol induces β 2 -AR-specific internalization, in CHO cells stably co-expressing β 1 -AR and β 2 -AR. These findings provide an additional mechanism for β 1 -AR down regulation in cardiomyocytes in heart failure, and the reason why β 2 -AR-specific agonists do not induce down regulation of β 1 -AR.
We confirmed that β 1 -AR and β 2 -AR formed heterooligomers in the CHO-K1 cells co-expressing the two receptors. This result is consistent with those of the previous reports using transient expression system. 16, 17) Several reports using transgenic and knockout mice suggest the functional importance of β 1 -AR/β 2 -AR heterooligomerization. For example, high levels of β 2 -AR overexpression have been reported to lead to an impairment of cardiac β 1 -AR function. 33) In addition, responses to β 2 -AR-specific agonist stimulation were lost in mice with homozygous deletion of the β 1 -AR, although the number and distribution of β 2 -AR in the heart of the knockout mice remained similar to those of wild type animals. 34) These reports are consistent with the hypothesis that each receptor depends on one another for their function.
In the present study, we speculate that the molecular mass of β 1 -AR fused to BFP is almost 50 kDa in SDS-PAGE from Fig. 2C . We also speculated that the molecular mass of β 2 -AR fused to EYFP is almost 80 kDa in SDS-PAGE from Fig. 2B . The reason why the molecular mass was so different between β 1 -AR fused to BFP and β 2 -AR fused to EYFP is still unclear. It is common that the molecular mass in SDS-PAGE is not consistent with the molecular mass predicted by amino acid sequence. In addition, the resolution of high molecular mass in SDS-PAGE is relatively low. Therefore, we cannot conclude the content of heteroologomer of β 1 -AR and β 2 -AR. In Fig. 2B , the bands represent some forms of EYFP-β 2 -AR. We speculated that the bands of 80 kDa, 130 kDa and 150 kDa are the monomer of β 2 -AR, heterodimer of β 1 -AR and β 2 -AR, and homodimer of β 2 -AR, respectively. However, further analysis is clearly needed to conclude the issue.
We demonstrated that heterooligomerization between β 1 -AR and β 2 -AR accelerates the isoproterenol-induced internalization of the β 1 -AR in the CHO-K1 cells stably co-expressing β 1 -AR and β 2 -AR, and did not affect the internalization of β 2 -AR. We speculate that isoproterenol induces internalization of heterooligomers of β 1 -AR and β 2 -AR without affecting the formation of heterooligomer. In fact, we observed that isoproterenol did not induce destabilization of the heterooligomers (Fig. 2C ). If this hypothesis is correct, internalization of β 1 -AR will increase and that of β 2 -AR will not change. Previously, Lavoie et al. reported that inhibition of agonist-promoted internalization of the β 2 -AR was observed upon co-expression of the β 1 -AR. 16) Although we cannot clarify the reason for the discrepancy between our data and the previous report at the present time, the differences of the host cell (CHO-K1 and HEK293) and expression system (stable and transient) may be involved in the underlying differences.
Overstimulation of β 1 -AR and β 2 -AR by overactivation of sympathetic nerve is one of the mechanisms of downreregulation of β-AR in heart failure. In addition, overuse of the agonist for β-AR for the patients of chronic heart failure is known to worsen prognosis of the patients. It is commonly believed that receptor downregulation occurs following receptor internalization. Down regulation of the two receptors is widely observed in various tissues co-expressing the receptors, such as cardiomyocytes especially in heart failure. If β 1 -AR is still resistant to internalization by agonist stimulation when the receptor forms heterooligomer, it is very difficult to explain how β 1 -AR is downregulated. The present study showed that β 1 -AR could internalize by isoproterenol stimulation, when β 1 -AR and β 2 -AR are stably co-expressed. Our results can explain, at least in part, the mechanism of downregulation of cardiac β 1 -AR when sympathetic nerve is overactivated, for example in falling heart.
It has been reported salbutamol induces co-internalization of β 2 -AR and α 1D -AR, which is hardly internalized by when expressing alone. 31) In the present study, salmeterol did not induce co-internalization between β 1 -AR and β 2 -AR. The immunoprecipitation-Western analysis suggests that salmeterol may destabilize heterooligomers between β 1 -AR and β 2 -AR, i.e., it is possible that binding only an agonist for one receptor subtype may destabilize the heterooligomers. At the moment, we cannot show how the heterooligomers are destabilized. In addition, it is of interest to clarify the effect of specific agonists for β 1 -AR on internalization of both β 1 -AR and β 2 -AR in the CHO-K1 cells stably co-expressing β 1 -AR and β 2 -AR. Unfortunately, there is no specific full agonist for β 1 -AR that is commercially available. Further analysis is needed to clarify the underlying mechanisms.
In summary, our results demonstrate that β 1 -AR and β 2 -AR can form heterooligomers, and that the heterooligomerization affects the property of the agonist-induced internalization. The present study provides novel insights into the mechanisms of cross talk between β 1 -AR and β 2 -AR, and that of downregulation of β 1 -AR in heart failure.
